948-30-1 Usage
General Description
3-Methyl-2,6-dinitrobenzonitrile is a chemical compound with the molecular formula C8H5N3O4. It is a yellow solid with a molecular weight of 195.14 g/mol. 3-Methyl-2,6-dinitrobenzonitrile is commonly used as a starting material in the synthesis of various organic compounds, particularly in the pharmaceutical and agrochemical industries. It has been shown to have antimicrobial and pesticidal properties, making it a valuable intermediate in the production of antimicrobial agents and pesticides. Additionally, 3-Methyl-2,6-dinitrobenzonitrile is a potent inhibitor of the enzyme DNA Polymerase β, which has implications in cancer research and the development of anticancer drugs. Its chemical properties and biological activities make it an important and versatile compound in the field of medicinal and agricultural chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 948-30-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,4 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 948-30:
(5*9)+(4*4)+(3*8)+(2*3)+(1*0)=91
91 % 10 = 1
So 948-30-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H5N3O4/c1-5-7(10(12)13)2-6(4-9)3-8(5)11(14)15/h2-3H,1H3
948-30-1Relevant articles and documents
Compound with dual inhibitory activity TDO, IDOO1 and application of compound for treating neurodegenerative disease (by machine translation)
-
Paragraph 0083; 0095-0098, (2020/10/06)
The present invention provides a compound of formula I, or a pharmaceutically acceptable salt thereof, or a solvate thereof, which can selectively inhibit TDO, IDOO1, which has a significant inhibitory effect on TDO and/or IDOO1. In addition, the prepared compound has a remarkable anti-tumor effect, has a certain treatment effect on's disease and's disease, and has a good application prospect in the field of medicine preparation. (by machine translation)
7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS
-
, (2008/06/13)
This invention involves involves the use of compounds having the following structure: STR1 wherein: (a) R is unsubstituted C 1-C. sub.3 alkanyl or alkenyl; and(b) R' is selected from hydrogen; unsubstituted C 1-C 3 alkanyl or alkenyl; unsubstituted